This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Monge, M. Articles by Abal, M. Search for Related Content PubMed PubMed Citation Articles by Monge, M. Articles by Abal, M.

ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer

¹ Research Institute Vall d'Hebron University Hospital; Departments of ² Gynecological Oncology and ³ Pathology, Vall d'Hebron University Hospital; ⁴ Pathology Department, Hospital del Mar; and ⁵ Faculty of Medicine, Autonoma University of Barcelona, Barcelona, Spain

Requests for reprints: Miguel Abal, Biomedical Research Unit, Research Institute Vall d'Hebron University Hospital, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain. Phone: 34-93-4893123; Fax: 34-93-4894015; E-mail: mabal{at}ir.vhebron.net.

We have described recently the Ets family transcription factor, ERM/ETV5, specifically up-regulated in endometrioid endometrial carcinoma (EEC) and associated with myometrial infiltration. Ets family members have been correlated to tumor progression by up-regulating the expression of matrix-degrading proteases. In the present study, we investigated the possibility that in EEC, ERM/ETV5 may act by inducing the expression of genes involved in extracellular matrix remodeling. Unraveling the molecular events associated with the initiation of tumor invasion would represent an obvious improvement for EEC patients. The overexpression of ERM/ETV5 induced scattering in the endometrial cancer cell line Hec-1A, correlating to increased matrix metalloproteinase-2 (MMP-2) gelatinase activity. Both chromatin immunoprecipitation and reversion experiments with RNA interference and specific MMP-2 inhibitor showed a functional link between ERM/ETV5 overexpression and MMP-2 activation. The increased MMP-2 activity associated with overexpressed ERM/ETV5 in a mouse model conferred invasive capacity to endometrial tumors. Orthotopically implanted overexpressing ERM/ETV5 tumors presented a more aggressive and infiltrative pattern of myometrial invasion. Finally, the specific localization of ERM/ETV5 and MMP-2 at the invasive front of myometrial infiltrating human endometrial carcinomas further reinforced the hypothesis of a role for ERM/ETV5 in the early steps of endometrial dissemination. Taken together, these results lead us to propose that in EEC, ERM/ETV5 acts through MMP-2 gelatinolytic activity to confer invasive capabilities, associated with an initial switch to myometrial infiltration. They also postulate ERM/ETV5 as a valuable marker for patient stratification and a transcription pathway that should be evaluated for therapies specifically targeting the initial steps of EEC dissemination. [Cancer Res 2007;67(14):6753–9]

This article has been cited by other articles:

				M. Monge, E. Colas, A. Doll, A. Gil-Moreno, J. Castellvi, B. Diaz, M. Gonzalez, R. Lopez-Lopez, J. Xercavins, R. Carreras, et al. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress Carcinogenesis, August 1, 2009; 30(8): 1288 - 1297. [Abstract] [Full Text] [PDF]

				G. Tyagi, K. Carnes, C. Morrow, N. V. Kostereva, G. C. Ekman, D. D. Meling, C. Hostetler, M. Griswold, K. M. Murphy, R. A. Hess, et al. Loss of Etv5 Decreases Proliferation and RET Levels in Neonatal Mouse Testicular Germ Cells and Causes an Abnormal First Wave of Spermatogenesis Biol Reprod, August 1, 2009; 81(2): 258 - 266. [Abstract] [Full Text] [PDF]

				Q. K.Y. Chan, H. Y.S. Ngan, P. P.C. Ip, V. W.S. Liu, W.C. Xue, and A. N.Y. Cheung Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis--a differential expression and functional analysis Carcinogenesis, January 1, 2009; 30(1): 114 - 121. [Abstract] [Full Text] [PDF]